| 1 | Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs. (Sohnle PG, Frank MM, Kirkpatrick CH) J Immunol 1976 Aug;117(2):523-30 62 Citations |
| 1 | Inhibition by sugars of Candida albicans adherence to human buccal mucosal cells and corneocytes in vitro. (Collins-Lech C, Kalbfleisch JH, Franson TR, Sohnle PG) Infect Immun 1984 Dec;46(3):831-4 36 Citations |
| 1 | Inhibition of neutrophil killing of Candida albicans pseudohyphae by substances which quench hypochlorous acid and chloramines. (Wagner DK, Collins-Lech C, Sohnle PG) Infect Immun 1986 Mar;51(3):731-5 50 Citations |
| 1 | Neutrophil death as a defence mechanism against Candida albicans infections. (McNamara MP, Wiessner JH, Collins-Lech C, Hahn BL, Sohnle PG) Lancet 1988 Nov 19;2(8621):1163-5 59 Citations |
| 1 | The fate of individual organisms during clearance of experimental cutaneous Candida albicans infections in mice. (Sohnle PG, Hahn BL) Acta Derm Venereol 1992 Aug;72(4):241-4 8 Citations |
| 1 | Inefficiency of in vivo candidacidal mechanisms in experimental subcutaneous infections with Candida albicans in mice. (Sohnle PG, Hahn BL, Radke L, Wagner DK) Infect Immun 1992 Sep;60(9):3940-2 2 Citations |
| 1 | Inhibition of pseudohyphal growth as a neutrophil-mediated host defense mechanism against experimental deep Candida albicans infections in mice. (Sohnle PG, Hahn BL) J Lab Clin Med 1993 Feb;121(2):235-43 11 Citations |
| 1 | Arrays of Candida albicans pseudohyphae that protect the organisms from neutrophil fungicidal mechanisms in experimental infections of mice. (Sohnle PG, Hahn BL, Wagner DK) J Med Vet Mycol 1994;32(1):21-30 4 Citations |
| 1 | Effect of abscess fluid supernatants on the kinetics of Candida albicans growth. (Radke LL, Hahn BL, Wagner DK, Sohnle PG) Clin Immunol Immunopathol 1994 Dec;73(3):344-9 39 Citations |
| 1 | Resistance of zinc-supplemented Candida albicans cells to the growth inhibitory effect of calprotectin. (Santhanagopalan V, Hahn BL, Sohnle PG) J Infect Dis 1995 May;171(5):1289-94 29 Citations |
| 1 | Use of a microtiter plate assay to detect the rate of killing of adherent Candida albicans by antifungal agents. (Hamers AD, Shay K, Hahn BL, Sohnle PG) Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996 Jan;81(1):44-9 14 Citations |
| 1 | Effect of fluconazole on viability of Candida albicans over extended periods of time. (Sohnle PG, Hahn BL, Erdmann MD) Antimicrob Agents Chemother 1996 Nov;40(11):2622-5 22 Citations |
| 1 | Inhibition of Candida albicans growth by calprotectin in the absence of direct contact with the organisms. (Sohnle PG, Hahn BL, Santhanagopalan V) J Infect Dis 1996 Dec;174(6):1369-72 82 Citations |
| 1 | Analysis of fluconazole effect on Candida albicans viability during extended incubations. (Sohnle PG, Hahn BL, Fassel TA, Kushnaryov VM) Med Mycol 1998 Feb;36(1):29-36 8 Citations |
| 1 | Comparison of fungal viability assays using Candida albicans yeast cells undergoing prolonged incubation in the absence of nutrients. (Hjertstedt J, Hahn BL, Kos WL, Sohnle PG) Mycoses 1998 Dec;41(11-12):487-92 13 Citations |
| 1 | Effect of metals on Candida albicans growth in the presence of chemical chelators and human abscess fluid. (Sohnle PG, Hahn BL, Karmarkar R) J Lab Clin Med 2001 Apr;137(4):284-9 22 Citations |
| 1 | Effect of prolonged fluconazole treatment on Candida albicans in diffusion chambers implanted into mice. (Sohnle PG, Hahn BL) Antimicrob Agents Chemother 2002 Oct;46(10):3175-9 3 Citations |
| 1 | Inefficient delivery of yeast cells as an explanation for reduced plating efficiency of Candida albicans. (Bhatti MA, Hjertstedt J, Hahn BL, Sohnle PG) Med Mycol 2002 Oct;40(5):465-9 3 Citations |
| 1 | Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. (Gantner BN, Simmons RM, Underhill DM) EMBO J 2005 Mar 23;24(6):1277-86 575 Citations |
| 1 | Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. (Hernández-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, Gaffen SL) Mucosal Immunol 2013 Sep;6(5):900-10 163 Citations |
| 1 | The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections. (Bishu S, Hernández-Santos N, Simpson-Abelson MR, Huppler AR, Conti HR, Ghilardi N, Mamo AJ, Gaffen SL) Infect Immun 2014 Mar;82(3):1173-80 57 Citations |
| 1 | Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections. (Conti HR, Peterson AC, Brane L, Huppler AR, Hernández-Santos N, Whibley N, Garg AV, Simpson-Abelson MR, Gibson GA, Mamo AJ, Osborne LC, Bishu S, Ghilardi N, Siebenlist U, Watkins SC, Artis D, McGeachy MJ, Gaffen SL) J Exp Med 2014 Sep 22;211(10):2075-84 234 Citations |
| 1 | A Candida albicans Strain Expressing Mammalian Interleukin-17A Results in Early Control of Fungal Growth during Disseminated Infection. (Huppler AR, Whibley N, Woolford CA, Childs EE, He J, Biswas PS, McGeachy MJ, Mitchell AP, Gaffen SL) Infect Immun 2015 Sep;83(9):3684-92 5 Citations |
| 1 | Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. (Verma AH, Richardson JP, Zhou C, Coleman BM, Moyes DL, Ho J, Huppler AR, Ramani K, McGeachy MJ, Mufazalov IA, Waisman A, Kane LP, Biswas PS, Hube B, Naglik JR, Gaffen SL) Sci Immunol 2017 Nov 03;2(17) 184 Citations |
| 1 | Titrating Gene Function in the Human Fungal Pathogen Candida albicans through Poly-Adenosine Tract Insertion. (Tournu H, Butts A, Palmer GE) mSphere 2019 May 22;4(3) 5 Citations |
| 1 | Inhibition of candida albicans and mixed salivary bacterial biofilms on antimicrobial loaded phosphated poly(Methyl methacrylate) (Dentino AR, Lee D, Dentino K, Guentsch A, Tahriri M) Antibiotics 2021;10(4) 2 Citations |
| 2 | Inhibition of Candida albicans and Mixed Salivary Bacterial Biofilms on Antimicrobial Loaded Phosphated Poly(methyl methacrylate). (Dentino AR, Lee D, Dentino K, Guentsch A, Tahriri M) Antibiotics (Basel) 2021 Apr 13;10(4) 2 Citations |
| 1 | Mucin O-glycans are natural inhibitors of Candida albicans pathogenicity. (Takagi J, Aoki K, Turner BS, Lamont S, Lehoux S, Kavanaugh N, Gulati M, Valle Arevalo A, Lawrence TJ, Kim CY, Bakshi B, Ishihara M, Nobile CJ, Cummings RD, Wozniak DJ, Tiemeyer M, Hevey R, Ribbeck K) Nat Chem Biol 2022 Jul;18(7):762-773 81 Citations |
© 2026 Clinical & Translational Science Institute